SYNTHROID vs TAFAMIDIS MEGLUMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SYNTHROID vs TAFAMIDIS MEGLUMINE: Safety Overview
| Metric | SYNTHROID | TAFAMIDIS MEGLUMINE |
|---|---|---|
| Total FAERS Reports | 208 | 4,405 |
| Deaths Reported | 5 | 1,718 |
| Death Rate | 2.4% | 39.0% |
| Hospitalizations | 26 | 1,334 |
| Average Patient Age | 56.2 yrs | 78.7 yrs |
| % Female Patients | N/A | 17.0% |
| FDA Approval Date | N/A | May 3, 2019 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | ORAL |
| Marketing Status | N/A | Discontinued |